Magdalena J. Orzechowska

Lodz, LD, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Clinical-Radiological Heterogeneity Within Intermediate Spinal Instability Neoplastic Scores (7-12): Factors Associated with Instrumented Stabilization in a Surgical Cohort.

Clinical-Radiological Heterogeneity Within Intermediate Spinal Instability Neoplastic Scores (7-12): Factors Associated with Instrumented Stabilization in a Surgical Cohort.

Journal: World neurosurgery

Published: May 20, 2026

Molecular Landscape of Prostate Cancer Across Age Groups: Impact on Prognosis and Treatment Outcomes.

Molecular Landscape of Prostate Cancer Across Age Groups: Impact on Prognosis and Treatment Outcomes.

Journal: International journal of molecular sciences

Published: September 18, 2025

Survival outcomes and toxicity profile after CT-guided HDR brachytherapy (interventional radiotherapy) for liver oligometastases in breast cancer patients: The BRALIBREST real world multicenter study.

Survival outcomes and toxicity profile after CT-guided HDR brachytherapy (interventional radiotherapy) for liver oligometastases in breast cancer patients: The BRALIBREST real world multicenter study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: August 31, 2025

CARBOMETASPINE: protocol for a multicenter, prospective, randomized controlled trial of carbonfiber spinal fixation in metastatic disease.

CARBOMETASPINE: protocol for a multicenter, prospective, randomized controlled trial of carbonfiber spinal fixation in metastatic disease.

Journal: BMC cancer

Published: July 12, 2025

Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial.

Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial.

Journal: BMC cancer

Published: January 07, 2025

Computed tomography guided high dose rate brachytherapy for induced oligoprogression of colorectal cancer liver metastases.

Computed tomography guided high dose rate brachytherapy for induced oligoprogression of colorectal cancer liver metastases.

Journal: Scientific reports

Published: December 06, 2024

Comprehensive cohort study: computer tomography-guided high-dose rate brachytherapy as metastasis-directed therapy for liver metastases from colorectal cancer in repeat oligoprogression.

Comprehensive cohort study: computer tomography-guided high-dose rate brachytherapy as metastasis-directed therapy for liver metastases from colorectal cancer in repeat oligoprogression.

Journal: La Radiologia medica

Published: October 11, 2024

miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomas.

miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomas.

Journal: Scientific reports

Published: August 09, 2024

The Case Series of Contralateral Interhemispheric Transfalcine Approach to Medial Parietooccipital Pathologies: Surgical Technique and Results.

The Case Series of Contralateral Interhemispheric Transfalcine Approach to Medial Parietooccipital Pathologies: Surgical Technique and Results.

Journal: Operative neurosurgery (Hagerstown, Md.)

Published: July 30, 2024

mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age.

mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age.

Journal: Diagnostics (Basel, Switzerland)

Published: November 14, 2023

High FLT3 expression increases immune-cell infiltration in the tumor microenvironment and correlates with prolonged disease-free survival in patients with non-small cell lung cancer.

High FLT3 expression increases immune-cell infiltration in the tumor microenvironment and correlates with prolonged disease-free survival in patients with non-small cell lung cancer.

Journal: Molecular oncology

Published: August 17, 2023

A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers.

A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers.

Journal: International journal of molecular sciences

Published: August 04, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026